Bilian Xu

593 citations
18 papers · 485 indexed · h-index 12
Topics
Bone Metabolism and Diseases (10 papers)Rheumatoid Arthritis Research and Therapies (5 papers)Bone and Joint Diseases (3 papers)
Partner nations
ChinaUnited StatesMacao

In The Last Decade

Bilian Xu

18 papers receiving 484 citations

Peers

Bilian Xu
Comparison fields: 5 of 80
  • Molecular Biology 286
  • Rheumatology 100
  • Cancer Research 96
  • Oncology 81
  • Orthopedics and Sports Medicine 79
Replace Guoju Hong with:
Guoju Hong China
Deming Xiao China
Chie Fukuda Japan
Xinghe Xue China
Nianhu Li China
Jacob Kenny Australia
kim hyunnam South Korea
Chi Zhou China
Qianhai Ding China
Mozhen Liu China
Bilian Xu relative to Guoju Hong China Guoju Hong's profile →
Citations per field
00.5×1.5×2.3×
Guoju Hong · 1×
Citations per year

Countries citing papers authored by Bilian Xu

Since Specialization
Citations

This map shows the geographic impact of Bilian Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bilian Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bilian Xu more than expected).

Fields of papers citing papers by Bilian Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bilian Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bilian Xu. The network helps show where Bilian Xu may publish in the future.

Co-authorship network of co-authors of Bilian Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Bilian Xu. A scholar is included among the top collaborators of Bilian Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bilian Xu. Bilian Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 10
2 6
3 14
4 29
5 14
6 16
7 58
8 17
9 8
10 11
11 25
12 52
13 43
14 23
15 114
16 42
17
[Effects of DanShenGuBao on biomechanical properties and bone mineral density of femur induced by retinoic acid in rats].
2
18
[Correlative changes of histomorphometry and biomechanical property of lumbar vertebrae body in ovariectomized rats].
1

About Bilian Xu

Bilian Xu is a scholar working on Orthopedics and Sports Medicine, Cancer Research and Rheumatology, having authored 18 papers that have together received 485 indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (10 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Bone and Joint Diseases (3 papers). The work is most often cited by research in Orthopedics and Sports Medicine (79 citations), Rheumatology (100 citations) and Cancer Research (96 citations). Bilian Xu has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Yuyu Liu, Liao Cui, Tie Wu, Yi Liu, Siyu Jiang, Yan Zhang, Min Yang, Yanzhi Liu, Pinghua Li and Le Zhou. Their work appears in journals such as PLoS ONE, Scientific Reports and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026